Product Code: ETC6182032 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s HERG screening market, related to detecting potential cardiac toxicity of new pharmaceutical compounds, is expanding as part of preclinical and clinical safety protocols. The screening process evaluates the risk of QT interval prolongation, which is essential for cardiovascular safety assessments. Regulatory bodies like the TGA mandate HERG testing for new drug applications, supporting growth in demand from pharmaceutical and biotech companies operating within or collaborating with Australian research facilities.
The HERG (human ether-à-go-go-related gene) screening market in Australia is becoming more prominent due to heightened safety regulations in pharmaceutical development. Pharmaceutical companies are increasingly investing in HERG channel screening to detect cardiotoxicity early during drug discovery processes. The demand for automated electrophysiology systems and high-throughput screening techniques is on the rise, ensuring compliance with international safety standards and improving the efficiency of drug pipelines.
Australia Herg Screening Market faces challenges related to the high cost of conducting screening tests, as well as the complexity of accurately identifying drugs that may cause heart rhythm abnormalities. While Herg screening is crucial for assessing drug safety, the growing number of new drugs entering the market presents an ongoing challenge in keeping up with the screening demands.
The HERG screening market, crucial for cardiac safety pharmacology, offers opportunities for investment in cutting-edge screening platforms, including high-throughput assays and 3D cell models. With Australia`s strong biotech ecosystem, investments in preclinical safety testing services and contract research organizations (CROs) can yield strong returns, especially from global pharma clients looking to outsource screening services.
The Australian government has implemented policies that support the regulation and development of cardiac safety testing, including hERG screening, which is critical in evaluating the risk of arrhythmias caused by drugs. The TGA, which regulates therapeutic goods in Australia, requires hERG screening for certain drugs as part of their safety and efficacy evaluation. These policies ensure that drugs approved for use in Australia meet stringent cardiac safety standards, driving the demand for hERG screening services and technologies in the market.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia HERG Screening Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia HERG Screening Market Revenues & Volume, 2021 & 2031F |
3.3 Australia HERG Screening Market - Industry Life Cycle |
3.4 Australia HERG Screening Market - Porter's Five Forces |
3.5 Australia HERG Screening Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia HERG Screening Market Revenues & Volume Share, By Ion Channel, 2021 & 2031F |
3.7 Australia HERG Screening Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia HERG Screening Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia HERG Screening Market Trends |
6 Australia HERG Screening Market, By Types |
6.1 Australia HERG Screening Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia HERG Screening Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia HERG Screening Market Revenues & Volume, By Gene KCNH2, 2021- 2031F |
6.1.4 Australia HERG Screening Market Revenues & Volume, By Mutant KCNH2, 2021- 2031F |
6.1.5 Australia HERG Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Australia HERG Screening Market, By Ion Channel |
6.2.1 Overview and Analysis |
6.2.2 Australia HERG Screening Market Revenues & Volume, By Voltage Gated, 2021- 2031F |
6.2.3 Australia HERG Screening Market Revenues & Volume, By Ligand Gated, 2021- 2031F |
6.2.4 Australia HERG Screening Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia HERG Screening Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia HERG Screening Market Revenues & Volume, By Antiarrhythmic, 2021- 2031F |
6.3.3 Australia HERG Screening Market Revenues & Volume, By Antipsychotic, 2021- 2031F |
6.3.4 Australia HERG Screening Market Revenues & Volume, By Antibiotic, 2021- 2031F |
6.3.5 Australia HERG Screening Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia HERG Screening Market Import-Export Trade Statistics |
7.1 Australia HERG Screening Market Export to Major Countries |
7.2 Australia HERG Screening Market Imports from Major Countries |
8 Australia HERG Screening Market Key Performance Indicators |
9 Australia HERG Screening Market - Opportunity Assessment |
9.1 Australia HERG Screening Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia HERG Screening Market Opportunity Assessment, By Ion Channel, 2021 & 2031F |
9.3 Australia HERG Screening Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia HERG Screening Market - Competitive Landscape |
10.1 Australia HERG Screening Market Revenue Share, By Companies, 2024 |
10.2 Australia HERG Screening Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |